Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
This grant funds high impact specialized innovation programs in clinical and translational science.
About this program
The Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science grant aims to support innovative projects that enhance clinical and translational research. It is designed for institutions and organizations that are engaged in clinical trials and seek to advance scientific knowledge and improve patient outcomes. The program encourages collaboration among researchers, healthcare providers, and industry partners to foster the development of new therapies and interventions. Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in clinical research. The grant provides funding to support innovative approaches that address significant challenges in clinical and translational science. Projects should demonstrate a clear potential for high impact and be aligned with the goals of improving health outcomes through research and innovation.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in clinical research.